Patients with | Overnight oximetry | Overnight standalone capnography | Overnight polygraphy | Overnight polysomnography with capnography | Overnight polysomnography with capnography and MSLT |
COPD | No indication | No indication | OSA screening | • OSA screening# • If other sleep disorders are suspected¶ | No indication |
Asthma | No indication | No indication | OSA screening | • OSA screening# • If other sleep disorders are suspected¶ | No indication |
Obesity | No indication | No indication | OSA screening | • OSA screening# • If other sleep disorders are suspected¶ | Hypersomnia screening in rare “hypothalamic” obesity (e.g. Prader–Willi syndrome) |
Amyotrophic lateral sclerosis | Regular (4 times per year) screening for hypoventilation onset | If available, (4 times per year) screening for hypoventilation onset | OSA screening | • OSA screening# • If other sleep disorders are suspected¶ | No indication |
Other neuromuscular diseases | No indication | Screening (once per year) for hypoventilation onset | OSA screening | • OSA screening# • If other sleep disorders are suspected¶ | Hypersomnia screening in myotrophic dystonia |
Interstitial lung disease | No indication | No indication | OSA screening | • OSA screening# • If other sleep disorders are suspected¶ | No indication |
OSA: obstructive sleep apnoea; MSLT: multiple sleep latency tests. #: if polysomnography is largely available in the local centre or if overnight polygraphy did not confirm the clinical suspicion of OSA; ¶: periodic limb movements, insomnia.